86-MM1143.00-0250 - letrozole | 112809-51-5
Lo sentimos, no se ha encontrado ningún producto con referencia 86-MM1143.00-0250, pero quizás quiera comprobar los siguientes productos similares:
Letrozole
CAS:Fórmula:C17H11N5Pureza:>98.0%(T)(HPLC)Forma y color:White to Light yellow powder to crystalPeso molecular:285.31Letrozole
CAS:Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFórmula:C17H11N5Forma y color:White Yellow Crystalline PowderPeso molecular:285.10145Letrozole
CAS:Letrozole (CGS 20267) is an Aromatase Inhibitor. The mechanism of action of letrozole is as an Aromatase Inhibitor.
Fórmula:C17H11N5Pureza:98.67% - 99.84%Forma y color:White To Off-Whitecrystalline PowderPeso molecular:285.3Letrozole
CAS:Fórmula:C17H11N5Pureza:≥ 98.0% (anhydrous basis)Forma y color:White to off-white powderPeso molecular:285.30Letrozole
CAS:Applications A nonsteroidal aromatase inhibitor structurally related to Fadrozole. Antineoplastic.
References Bhatnagar, A.S., et al: J. Steroid Biochem. Mol. Biol., 37, 1021 (1990), Pfister, C.U., et al.: J. Pharm. Sci., 83, 520 (1994), Lipton, A., et al.: Cancer, 75, 2132 (1995),Fórmula:C17H11N5Forma y color:YellowPeso molecular:285.30Letrozole
CAS:Producto controladoNon-steroidal inhibitor of aromataseFórmula:C17H11N5Pureza:Min. 95%Forma y color:White PowderPeso molecular:285.3 g/molLetrozole
CAS:Producto controladoLetrozole is a non-steroidal aromatase inhibitor, which is synthesized chemically. This product acts by inhibiting the aromatase enzyme, thus reducing estrogen production in the body. Estrogen plays a critical role in the proliferation of hormone-sensitive breast cancer cells, and by lowering its levels, Letrozole effectively impedes cancer growth.Fórmula:C17H11N5Peso molecular:285.30 g/mol
